Andrea D Giamanco, RPH | |
6999 Jackrabbit Ln, Belgrade, MT 59714-8961 | |
(406) 388-1696 | |
Not Available |
Full Name | Andrea D Giamanco |
---|---|
Gender | Female |
Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
Location | 6999 Jackrabbit Ln, Belgrade, Montana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043559883 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 5098 (Montana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Andrea D Giamanco, RPH 6999 Jackrabbit Ln, Belgrade, MT 59714-8961 Ph: (406) 360-6241 | Andrea D Giamanco, RPH 6999 Jackrabbit Ln, Belgrade, MT 59714-8961 Ph: (406) 388-1696 |
News Archive
DermaGen AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - announced that Dermagen AB has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a novel antimicrobial peptide (AMP) treatment for atopic dermatitis. Atopic dermatitis is a chronic inflammatory skin disease where dry skin and the skin's weakened barrier function make patients susceptible to colonization by microorganisms, a triggering or exacerbating factor of the disease.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with VHA Inc., a national health care network serving 1,400 not-for-profit hospitals and 30,000 non-acute care providers across the nation.
Lesbian, gay, bisexual, transgender and questioning (LGBTQ) youths are more likely to end up in foster care or unstable housing and suffer negative outcomes, such as substance abuse or mental health issues, while living in the child welfare system, according to new research from The University of Texas at Austin.
Cordis Corporation today announced the European launch of its next generation of bare metal stent system - PRESILLION(TM) PLUS. The new stent system, which improves upon the ground-breaking PRESILLION(TM), features important technological advances designed to gain easier access to distal lesions and help restore the artery's natural form.
› Verified 9 days ago
David Lee Jurenka, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 Engberg Ln, Belgrade, MT 59714 Phone: 406-240-4577 | |
William Henry Mitchell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6999 Jackrabbit Ln, Belgrade, MT 59714 Phone: 406-388-1713 Fax: 406-388-1737 |